Serum biomarker profiles of interleukin-6, tumor necrosis factor alpha, matrix-metalloproteinase-2, and vascular endothelial growth factor in endometriosis staging
article
OA: gold
CC0
⤵ 5 in-corpus citations
Abstract
Background: The focus of this study was to compare serum biomarkers: interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), matrix-metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in endometriosis stage I-II and stage III-IV. Methods: This is a cross-sectional study. Forty endometriosis patients were diagnosed using laparoscopy procedure. Serum sample was taken before the surgery. The serum biomarkers (IL-6, TNF-α, MMP-2, and VEGF) were analyzed with ELISA method at the end of research. Mean of serum biomarkers in endometrosis stage I-II and stage III-IV were compared using unpaired t-test. Variables that show significant mean difference were tested using ROC measurement and the optimal cut-off point was determined. Results: There was no significant difference in mean serum biomarkers level of IL-6, TNF-α, and MMP-2 between endometriosis stage I-II and stage III-IV (1.58 ± 0.78 vs 1.55 ± 0.98 pg/mL, 1.5 ± 0.47 vs 1.49 ± 0.29 pg/mL, and 152.04 ± 27.32 vs 140.98 ± 28.08 ng/mL, respectively). On the other hand, the comparison of VEGF level in endometriosis stage I-II and stage III-IV demonstrated significant difference (289.76 ± 188.13 vs 581.29 ± 512.85 pg/mL (p < 0.05)). Mean difference of VEGF had AUC of 74.5%. Optimal cut-off point for VEGF was 314.75 pg/mL with sensitivity 78.6% and specificity 69.2%. Conclusion: This study showed that serum biomarkers of VEGF level (but not IL-6, TNF-α, and MMP-2) can be used to measure the degree of severity in endometriosis. VEGF level of 314.75 pg/mL represents the cut-off point between lower and higher stage of severity.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- A logistic model for the prediction of endometriosis via openalex
- Dampak penambahan Gonadotropin Releasing Hormon Analog pada operasi laparoskopi terhadap manifestasi klinis, imunologis dan kualitas hidup penderita endometriosis via openalex
- Development of endometriosis-like lesions after transplantation of human endometrial fragments onto the chick embryo chorioallantoic membrane via openalex
- Endometriosis and infertility via openalex
- ENDOMETRIOSIS AND INFERTILITY via openalex
- Immunobiology of endometriosis via openalex
- Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis via openalex
- Interleukin-6: another piece of the endometriosis-cytokine puzzle via openalex
- Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis via openalex
- Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers via openalex
- ORIGINAL ARTICLE: Tumor Necrosis Factor (TNF)–TNF Receptor Gene Polymorphisms and Their Serum Levels in Korean Women with Endometriosis via openalex
- Pathogenic mechanisms in endometriosis-associated infertility via openalex
- Peripheral biomarkers of endometriosis: a systematic review via openalex
- Relationship between Microvascular Density and Expression of Vascular Endothelial Growth Factor in Patients with Ovarian Endometriosis via openalex
- Role of cytokines in endometriosis via openalex
- Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines via openalex
- Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis via openalex
- Vascular endothelial growth factor and endometriotic angiogenesis via openalex
- Vascular endothelial growth factor concentrations in the serum and peritoneal fluid of women with endometriosis via openalex
- W6683044223 via openalex
- W2016431623 via openalex
- W2029598549 via openalex
- W2041767365 via openalex
- W2049037562 via openalex
- W2126728673 via openalex
- W2140246703 via openalex
- W2171863626 via openalex
- W6654678134 via openalex
Cited by (5)
- Disease Severity- and Hormonal Status-Dependent Alterations of EGF and MIF in the Serum of Endometriosis Patients 2025
- Endometriosis: A Comprehensive and Concise Review of Potential Biomarkers and Treatment Therapies 2024
- Serum Level of Ligand Programmed Death-1 in Endometriosis 2022
- Higher IL-1beta level in the follicular liquid of endometriosis compared with non-endometriosis patients 2020
- EKSPRESI INTERLEUKIN-1 (IL-1) Β PADA ENDOMETRIOSIS, KARSINOMA ENDOMETRIOID DAN KARSINOMA SEROSUM OVARIUM 2017
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK